Antihypertensive Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Antihypertensive in global, including the following market information:
Global Antihypertensive Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antihypertensive Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Antihypertensive companies in 2021 (%)
The global Antihypertensive market was valued at 19810 million in 2021 and is projected to reach US$ 22820 million by 2028, at a CAGR of 2.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diuretics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antihypertensive include Pfizer, Norvatis, Merck & Co., Sanofi, AstraZeneca, GSK, Daiichi-Sankyo, Boehringer-Ingelheim and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antihypertensive manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antihypertensive Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antihypertensive Market Segment Percentages, by Type, 2021 (%)
Global Antihypertensive Market Segment Percentages, by Application, 2021 (%)
Global Antihypertensive Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Antihypertensive revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antihypertensive revenues share in global market, 2021 (%)
Key companies Antihypertensive sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Antihypertensive sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Antihypertensive Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antihypertensive Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Antihypertensive companies in 2021 (%)
The global Antihypertensive market was valued at 19810 million in 2021 and is projected to reach US$ 22820 million by 2028, at a CAGR of 2.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diuretics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antihypertensive include Pfizer, Norvatis, Merck & Co., Sanofi, AstraZeneca, GSK, Daiichi-Sankyo, Boehringer-Ingelheim and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antihypertensive manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antihypertensive Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antihypertensive Market Segment Percentages, by Type, 2021 (%)
- Diuretics
- Angiotensin Converting Enzyme (ACE) Inhibitors
- Angiotensin Receptor Blockers (ARBs)
- Calcium Channel Blockers
- Beta Blockers
- Alpha Blockers
- Vasodilators & Renin Inhibitors
Global Antihypertensive Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Global Antihypertensive Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Antihypertensive revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antihypertensive revenues share in global market, 2021 (%)
Key companies Antihypertensive sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Antihypertensive sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Norvatis
- Merck & Co.
- Sanofi
- AstraZeneca
- GSK
- Daiichi-Sankyo
- Boehringer-Ingelheim
- Bayer
- Johnson & Johnson
- Bristol-Myers Squibb
- Tekeda
- Ranbaxy Laboratories
- Shihuida Pharm
- Second Pharmaceutical
- Lupin Limited.
- Yangtze River Pharmaceutical
- Hengrui Medicine
- Qilu Pharmaceutical
- HUALON
- Dawnrays
- HISUN Pharmceutical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Antihypertensive Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antihypertensive Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ANTIHYPERTENSIVE OVERALL MARKET SIZE
2.1 Global Antihypertensive Market Size: 2021 VS 2028
2.2 Global Antihypertensive Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antihypertensive Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Antihypertensive Players in Global Market
3.2 Top Global Antihypertensive Companies Ranked by Revenue
3.3 Global Antihypertensive Revenue by Companies
3.4 Global Antihypertensive Sales by Companies
3.5 Global Antihypertensive Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antihypertensive Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antihypertensive Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antihypertensive Players in Global Market
3.8.1 List of Global Tier 1 Antihypertensive Companies
3.8.2 List of Global Tier 2 and Tier 3 Antihypertensive Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Antihypertensive Market Size Markets, 2021 & 2028
4.1.2 Diuretics
4.1.3 Angiotensin Converting Enzyme (ACE) Inhibitors
4.1.4 Angiotensin Receptor Blockers (ARBs)
4.1.5 Calcium Channel Blockers
4.1.6 Beta Blockers
4.1.7 Alpha Blockers
4.1.8 Vasodilators & Renin Inhibitors
4.2 By Type - Global Antihypertensive Revenue & Forecasts
4.2.1 By Type - Global Antihypertensive Revenue, 2017-2022
4.2.2 By Type - Global Antihypertensive Revenue, 2023-2028
4.2.3 By Type - Global Antihypertensive Revenue Market Share, 2017-2028
4.3 By Type - Global Antihypertensive Sales & Forecasts
4.3.1 By Type - Global Antihypertensive Sales, 2017-2022
4.3.2 By Type - Global Antihypertensive Sales, 2023-2028
4.3.3 By Type - Global Antihypertensive Sales Market Share, 2017-2028
4.4 By Type - Global Antihypertensive Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Antihypertensive Market Size, 2021 & 2028
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.1.5 Others
5.2 By Application - Global Antihypertensive Revenue & Forecasts
5.2.1 By Application - Global Antihypertensive Revenue, 2017-2022
5.2.2 By Application - Global Antihypertensive Revenue, 2023-2028
5.2.3 By Application - Global Antihypertensive Revenue Market Share, 2017-2028
5.3 By Application - Global Antihypertensive Sales & Forecasts
5.3.1 By Application - Global Antihypertensive Sales, 2017-2022
5.3.2 By Application - Global Antihypertensive Sales, 2023-2028
5.3.3 By Application - Global Antihypertensive Sales Market Share, 2017-2028
5.4 By Application - Global Antihypertensive Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Antihypertensive Market Size, 2021 & 2028
6.2 By Region - Global Antihypertensive Revenue & Forecasts
6.2.1 By Region - Global Antihypertensive Revenue, 2017-2022
6.2.2 By Region - Global Antihypertensive Revenue, 2023-2028
6.2.3 By Region - Global Antihypertensive Revenue Market Share, 2017-2028
6.3 By Region - Global Antihypertensive Sales & Forecasts
6.3.1 By Region - Global Antihypertensive Sales, 2017-2022
6.3.2 By Region - Global Antihypertensive Sales, 2023-2028
6.3.3 By Region - Global Antihypertensive Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Antihypertensive Revenue, 2017-2028
6.4.2 By Country - North America Antihypertensive Sales, 2017-2028
6.4.3 US Antihypertensive Market Size, 2017-2028
6.4.4 Canada Antihypertensive Market Size, 2017-2028
6.4.5 Mexico Antihypertensive Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Antihypertensive Revenue, 2017-2028
6.5.2 By Country - Europe Antihypertensive Sales, 2017-2028
6.5.3 Germany Antihypertensive Market Size, 2017-2028
6.5.4 France Antihypertensive Market Size, 2017-2028
6.5.5 U.K. Antihypertensive Market Size, 2017-2028
6.5.6 Italy Antihypertensive Market Size, 2017-2028
6.5.7 Russia Antihypertensive Market Size, 2017-2028
6.5.8 Nordic Countries Antihypertensive Market Size, 2017-2028
6.5.9 Benelux Antihypertensive Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Antihypertensive Revenue, 2017-2028
6.6.2 By Region - Asia Antihypertensive Sales, 2017-2028
6.6.3 China Antihypertensive Market Size, 2017-2028
6.6.4 Japan Antihypertensive Market Size, 2017-2028
6.6.5 South Korea Antihypertensive Market Size, 2017-2028
6.6.6 Southeast Asia Antihypertensive Market Size, 2017-2028
6.6.7 India Antihypertensive Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Antihypertensive Revenue, 2017-2028
6.7.2 By Country - South America Antihypertensive Sales, 2017-2028
6.7.3 Brazil Antihypertensive Market Size, 2017-2028
6.7.4 Argentina Antihypertensive Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antihypertensive Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Antihypertensive Sales, 2017-2028
6.8.3 Turkey Antihypertensive Market Size, 2017-2028
6.8.4 Israel Antihypertensive Market Size, 2017-2028
6.8.5 Saudi Arabia Antihypertensive Market Size, 2017-2028
6.8.6 UAE Antihypertensive Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Antihypertensive Major Product Offerings
7.1.4 Pfizer Antihypertensive Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 Norvatis
7.2.1 Norvatis Corporate Summary
7.2.2 Norvatis Business Overview
7.2.3 Norvatis Antihypertensive Major Product Offerings
7.2.4 Norvatis Antihypertensive Sales and Revenue in Global (2017-2022)
7.2.5 Norvatis Key News
7.3 Merck & Co.
7.3.1 Merck & Co. Corporate Summary
7.3.2 Merck & Co. Business Overview
7.3.3 Merck & Co. Antihypertensive Major Product Offerings
7.3.4 Merck & Co. Antihypertensive Sales and Revenue in Global (2017-2022)
7.3.5 Merck & Co. Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Antihypertensive Major Product Offerings
7.4.4 Sanofi Antihypertensive Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Antihypertensive Major Product Offerings
7.5.4 AstraZeneca Antihypertensive Sales and Revenue in Global (2017-2022)
7.5.5 AstraZeneca Key News
7.6 GSK
7.6.1 GSK Corporate Summary
7.6.2 GSK Business Overview
7.6.3 GSK Antihypertensive Major Product Offerings
7.6.4 GSK Antihypertensive Sales and Revenue in Global (2017-2022)
7.6.5 GSK Key News
7.7 Daiichi-Sankyo
7.7.1 Daiichi-Sankyo Corporate Summary
7.7.2 Daiichi-Sankyo Business Overview
7.7.3 Daiichi-Sankyo Antihypertensive Major Product Offerings
7.7.4 Daiichi-Sankyo Antihypertensive Sales and Revenue in Global (2017-2022)
7.7.5 Daiichi-Sankyo Key News
7.8 Boehringer-Ingelheim
7.8.1 Boehringer-Ingelheim Corporate Summary
7.8.2 Boehringer-Ingelheim Business Overview
7.8.3 Boehringer-Ingelheim Antihypertensive Major Product Offerings
7.8.4 Boehringer-Ingelheim Antihypertensive Sales and Revenue in Global (2017-2022)
7.8.5 Boehringer-Ingelheim Key News
7.9 Bayer
7.9.1 Bayer Corporate Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Antihypertensive Major Product Offerings
7.9.4 Bayer Antihypertensive Sales and Revenue in Global (2017-2022)
7.9.5 Bayer Key News
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Corporate Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Antihypertensive Major Product Offerings
7.10.4 Johnson & Johnson Antihypertensive Sales and Revenue in Global (2017-2022)
7.10.5 Johnson & Johnson Key News
7.11 Bristol-Myers Squibb
7.11.1 Bristol-Myers Squibb Corporate Summary
7.11.2 Bristol-Myers Squibb Antihypertensive Business Overview
7.11.3 Bristol-Myers Squibb Antihypertensive Major Product Offerings
7.11.4 Bristol-Myers Squibb Antihypertensive Sales and Revenue in Global (2017-2022)
7.11.5 Bristol-Myers Squibb Key News
7.12 Tekeda
7.12.1 Tekeda Corporate Summary
7.12.2 Tekeda Antihypertensive Business Overview
7.12.3 Tekeda Antihypertensive Major Product Offerings
7.12.4 Tekeda Antihypertensive Sales and Revenue in Global (2017-2022)
7.12.5 Tekeda Key News
7.13 Ranbaxy Laboratories
7.13.1 Ranbaxy Laboratories Corporate Summary
7.13.2 Ranbaxy Laboratories Antihypertensive Business Overview
7.13.3 Ranbaxy Laboratories Antihypertensive Major Product Offerings
7.13.4 Ranbaxy Laboratories Antihypertensive Sales and Revenue in Global (2017-2022)
7.13.5 Ranbaxy Laboratories Key News
7.14 Shihuida Pharm
7.14.1 Shihuida Pharm Corporate Summary
7.14.2 Shihuida Pharm Business Overview
7.14.3 Shihuida Pharm Antihypertensive Major Product Offerings
7.14.4 Shihuida Pharm Antihypertensive Sales and Revenue in Global (2017-2022)
7.14.5 Shihuida Pharm Key News
7.15 Second Pharmaceutical
7.15.1 Second Pharmaceutical Corporate Summary
7.15.2 Second Pharmaceutical Business Overview
7.15.3 Second Pharmaceutical Antihypertensive Major Product Offerings
7.15.4 Second Pharmaceutical Antihypertensive Sales and Revenue in Global (2017-2022)
7.15.5 Second Pharmaceutical Key News
7.16 Lupin Limited.
7.16.1 Lupin Limited. Corporate Summary
7.16.2 Lupin Limited. Business Overview
7.16.3 Lupin Limited. Antihypertensive Major Product Offerings
7.16.4 Lupin Limited. Antihypertensive Sales and Revenue in Global (2017-2022)
7.16.5 Lupin Limited. Key News
7.17 Yangtze River Pharmaceutical
7.17.1 Yangtze River Pharmaceutical Corporate Summary
7.17.2 Yangtze River Pharmaceutical Business Overview
7.17.3 Yangtze River Pharmaceutical Antihypertensive Major Product Offerings
7.17.4 Yangtze River Pharmaceutical Antihypertensive Sales and Revenue in Global (2017-2022)
7.17.5 Yangtze River Pharmaceutical Key News
7.18 Hengrui Medicine
7.18.1 Hengrui Medicine Corporate Summary
7.18.2 Hengrui Medicine Business Overview
7.18.3 Hengrui Medicine Antihypertensive Major Product Offerings
7.18.4 Hengrui Medicine Antihypertensive Sales and Revenue in Global (2017-2022)
7.18.5 Hengrui Medicine Key News
7.19 Qilu Pharmaceutical
7.19.1 Qilu Pharmaceutical Corporate Summary
7.19.2 Qilu Pharmaceutical Business Overview
7.19.3 Qilu Pharmaceutical Antihypertensive Major Product Offerings
7.19.4 Qilu Pharmaceutical Antihypertensive Sales and Revenue in Global (2017-2022)
7.19.5 Qilu Pharmaceutical Key News
7.20 HUALON
7.20.1 HUALON Corporate Summary
7.20.2 HUALON Business Overview
7.20.3 HUALON Antihypertensive Major Product Offerings
7.20.4 HUALON Antihypertensive Sales and Revenue in Global (2017-2022)
7.20.5 HUALON Key News
7.21 Dawnrays
7.21.1 Dawnrays Corporate Summary
7.21.2 Dawnrays Business Overview
7.21.3 Dawnrays Antihypertensive Major Product Offerings
7.21.4 Dawnrays Antihypertensive Sales and Revenue in Global (2017-2022)
7.21.5 Dawnrays Key News
7.22 HISUN Pharmceutical
7.22.1 HISUN Pharmceutical Corporate Summary
7.22.2 HISUN Pharmceutical Business Overview
7.22.3 HISUN Pharmceutical Antihypertensive Major Product Offerings
7.22.4 HISUN Pharmceutical Antihypertensive Sales and Revenue in Global (2017-2022)
7.22.5 HISUN Pharmceutical Key News
8 GLOBAL ANTIHYPERTENSIVE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Antihypertensive Production Capacity, 2017-2028
8.2 Antihypertensive Production Capacity of Key Manufacturers in Global Market
8.3 Global Antihypertensive Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ANTIHYPERTENSIVE SUPPLY CHAIN ANALYSIS
10.1 Antihypertensive Industry Value Chain
10.2 Antihypertensive Upstream Market
10.3 Antihypertensive Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antihypertensive Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Antihypertensive Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antihypertensive Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ANTIHYPERTENSIVE OVERALL MARKET SIZE
2.1 Global Antihypertensive Market Size: 2021 VS 2028
2.2 Global Antihypertensive Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antihypertensive Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Antihypertensive Players in Global Market
3.2 Top Global Antihypertensive Companies Ranked by Revenue
3.3 Global Antihypertensive Revenue by Companies
3.4 Global Antihypertensive Sales by Companies
3.5 Global Antihypertensive Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antihypertensive Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antihypertensive Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antihypertensive Players in Global Market
3.8.1 List of Global Tier 1 Antihypertensive Companies
3.8.2 List of Global Tier 2 and Tier 3 Antihypertensive Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Antihypertensive Market Size Markets, 2021 & 2028
4.1.2 Diuretics
4.1.3 Angiotensin Converting Enzyme (ACE) Inhibitors
4.1.4 Angiotensin Receptor Blockers (ARBs)
4.1.5 Calcium Channel Blockers
4.1.6 Beta Blockers
4.1.7 Alpha Blockers
4.1.8 Vasodilators & Renin Inhibitors
4.2 By Type - Global Antihypertensive Revenue & Forecasts
4.2.1 By Type - Global Antihypertensive Revenue, 2017-2022
4.2.2 By Type - Global Antihypertensive Revenue, 2023-2028
4.2.3 By Type - Global Antihypertensive Revenue Market Share, 2017-2028
4.3 By Type - Global Antihypertensive Sales & Forecasts
4.3.1 By Type - Global Antihypertensive Sales, 2017-2022
4.3.2 By Type - Global Antihypertensive Sales, 2023-2028
4.3.3 By Type - Global Antihypertensive Sales Market Share, 2017-2028
4.4 By Type - Global Antihypertensive Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Antihypertensive Market Size, 2021 & 2028
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.1.5 Others
5.2 By Application - Global Antihypertensive Revenue & Forecasts
5.2.1 By Application - Global Antihypertensive Revenue, 2017-2022
5.2.2 By Application - Global Antihypertensive Revenue, 2023-2028
5.2.3 By Application - Global Antihypertensive Revenue Market Share, 2017-2028
5.3 By Application - Global Antihypertensive Sales & Forecasts
5.3.1 By Application - Global Antihypertensive Sales, 2017-2022
5.3.2 By Application - Global Antihypertensive Sales, 2023-2028
5.3.3 By Application - Global Antihypertensive Sales Market Share, 2017-2028
5.4 By Application - Global Antihypertensive Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Antihypertensive Market Size, 2021 & 2028
6.2 By Region - Global Antihypertensive Revenue & Forecasts
6.2.1 By Region - Global Antihypertensive Revenue, 2017-2022
6.2.2 By Region - Global Antihypertensive Revenue, 2023-2028
6.2.3 By Region - Global Antihypertensive Revenue Market Share, 2017-2028
6.3 By Region - Global Antihypertensive Sales & Forecasts
6.3.1 By Region - Global Antihypertensive Sales, 2017-2022
6.3.2 By Region - Global Antihypertensive Sales, 2023-2028
6.3.3 By Region - Global Antihypertensive Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Antihypertensive Revenue, 2017-2028
6.4.2 By Country - North America Antihypertensive Sales, 2017-2028
6.4.3 US Antihypertensive Market Size, 2017-2028
6.4.4 Canada Antihypertensive Market Size, 2017-2028
6.4.5 Mexico Antihypertensive Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Antihypertensive Revenue, 2017-2028
6.5.2 By Country - Europe Antihypertensive Sales, 2017-2028
6.5.3 Germany Antihypertensive Market Size, 2017-2028
6.5.4 France Antihypertensive Market Size, 2017-2028
6.5.5 U.K. Antihypertensive Market Size, 2017-2028
6.5.6 Italy Antihypertensive Market Size, 2017-2028
6.5.7 Russia Antihypertensive Market Size, 2017-2028
6.5.8 Nordic Countries Antihypertensive Market Size, 2017-2028
6.5.9 Benelux Antihypertensive Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Antihypertensive Revenue, 2017-2028
6.6.2 By Region - Asia Antihypertensive Sales, 2017-2028
6.6.3 China Antihypertensive Market Size, 2017-2028
6.6.4 Japan Antihypertensive Market Size, 2017-2028
6.6.5 South Korea Antihypertensive Market Size, 2017-2028
6.6.6 Southeast Asia Antihypertensive Market Size, 2017-2028
6.6.7 India Antihypertensive Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Antihypertensive Revenue, 2017-2028
6.7.2 By Country - South America Antihypertensive Sales, 2017-2028
6.7.3 Brazil Antihypertensive Market Size, 2017-2028
6.7.4 Argentina Antihypertensive Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antihypertensive Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Antihypertensive Sales, 2017-2028
6.8.3 Turkey Antihypertensive Market Size, 2017-2028
6.8.4 Israel Antihypertensive Market Size, 2017-2028
6.8.5 Saudi Arabia Antihypertensive Market Size, 2017-2028
6.8.6 UAE Antihypertensive Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Antihypertensive Major Product Offerings
7.1.4 Pfizer Antihypertensive Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 Norvatis
7.2.1 Norvatis Corporate Summary
7.2.2 Norvatis Business Overview
7.2.3 Norvatis Antihypertensive Major Product Offerings
7.2.4 Norvatis Antihypertensive Sales and Revenue in Global (2017-2022)
7.2.5 Norvatis Key News
7.3 Merck & Co.
7.3.1 Merck & Co. Corporate Summary
7.3.2 Merck & Co. Business Overview
7.3.3 Merck & Co. Antihypertensive Major Product Offerings
7.3.4 Merck & Co. Antihypertensive Sales and Revenue in Global (2017-2022)
7.3.5 Merck & Co. Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Antihypertensive Major Product Offerings
7.4.4 Sanofi Antihypertensive Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Antihypertensive Major Product Offerings
7.5.4 AstraZeneca Antihypertensive Sales and Revenue in Global (2017-2022)
7.5.5 AstraZeneca Key News
7.6 GSK
7.6.1 GSK Corporate Summary
7.6.2 GSK Business Overview
7.6.3 GSK Antihypertensive Major Product Offerings
7.6.4 GSK Antihypertensive Sales and Revenue in Global (2017-2022)
7.6.5 GSK Key News
7.7 Daiichi-Sankyo
7.7.1 Daiichi-Sankyo Corporate Summary
7.7.2 Daiichi-Sankyo Business Overview
7.7.3 Daiichi-Sankyo Antihypertensive Major Product Offerings
7.7.4 Daiichi-Sankyo Antihypertensive Sales and Revenue in Global (2017-2022)
7.7.5 Daiichi-Sankyo Key News
7.8 Boehringer-Ingelheim
7.8.1 Boehringer-Ingelheim Corporate Summary
7.8.2 Boehringer-Ingelheim Business Overview
7.8.3 Boehringer-Ingelheim Antihypertensive Major Product Offerings
7.8.4 Boehringer-Ingelheim Antihypertensive Sales and Revenue in Global (2017-2022)
7.8.5 Boehringer-Ingelheim Key News
7.9 Bayer
7.9.1 Bayer Corporate Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Antihypertensive Major Product Offerings
7.9.4 Bayer Antihypertensive Sales and Revenue in Global (2017-2022)
7.9.5 Bayer Key News
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Corporate Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Antihypertensive Major Product Offerings
7.10.4 Johnson & Johnson Antihypertensive Sales and Revenue in Global (2017-2022)
7.10.5 Johnson & Johnson Key News
7.11 Bristol-Myers Squibb
7.11.1 Bristol-Myers Squibb Corporate Summary
7.11.2 Bristol-Myers Squibb Antihypertensive Business Overview
7.11.3 Bristol-Myers Squibb Antihypertensive Major Product Offerings
7.11.4 Bristol-Myers Squibb Antihypertensive Sales and Revenue in Global (2017-2022)
7.11.5 Bristol-Myers Squibb Key News
7.12 Tekeda
7.12.1 Tekeda Corporate Summary
7.12.2 Tekeda Antihypertensive Business Overview
7.12.3 Tekeda Antihypertensive Major Product Offerings
7.12.4 Tekeda Antihypertensive Sales and Revenue in Global (2017-2022)
7.12.5 Tekeda Key News
7.13 Ranbaxy Laboratories
7.13.1 Ranbaxy Laboratories Corporate Summary
7.13.2 Ranbaxy Laboratories Antihypertensive Business Overview
7.13.3 Ranbaxy Laboratories Antihypertensive Major Product Offerings
7.13.4 Ranbaxy Laboratories Antihypertensive Sales and Revenue in Global (2017-2022)
7.13.5 Ranbaxy Laboratories Key News
7.14 Shihuida Pharm
7.14.1 Shihuida Pharm Corporate Summary
7.14.2 Shihuida Pharm Business Overview
7.14.3 Shihuida Pharm Antihypertensive Major Product Offerings
7.14.4 Shihuida Pharm Antihypertensive Sales and Revenue in Global (2017-2022)
7.14.5 Shihuida Pharm Key News
7.15 Second Pharmaceutical
7.15.1 Second Pharmaceutical Corporate Summary
7.15.2 Second Pharmaceutical Business Overview
7.15.3 Second Pharmaceutical Antihypertensive Major Product Offerings
7.15.4 Second Pharmaceutical Antihypertensive Sales and Revenue in Global (2017-2022)
7.15.5 Second Pharmaceutical Key News
7.16 Lupin Limited.
7.16.1 Lupin Limited. Corporate Summary
7.16.2 Lupin Limited. Business Overview
7.16.3 Lupin Limited. Antihypertensive Major Product Offerings
7.16.4 Lupin Limited. Antihypertensive Sales and Revenue in Global (2017-2022)
7.16.5 Lupin Limited. Key News
7.17 Yangtze River Pharmaceutical
7.17.1 Yangtze River Pharmaceutical Corporate Summary
7.17.2 Yangtze River Pharmaceutical Business Overview
7.17.3 Yangtze River Pharmaceutical Antihypertensive Major Product Offerings
7.17.4 Yangtze River Pharmaceutical Antihypertensive Sales and Revenue in Global (2017-2022)
7.17.5 Yangtze River Pharmaceutical Key News
7.18 Hengrui Medicine
7.18.1 Hengrui Medicine Corporate Summary
7.18.2 Hengrui Medicine Business Overview
7.18.3 Hengrui Medicine Antihypertensive Major Product Offerings
7.18.4 Hengrui Medicine Antihypertensive Sales and Revenue in Global (2017-2022)
7.18.5 Hengrui Medicine Key News
7.19 Qilu Pharmaceutical
7.19.1 Qilu Pharmaceutical Corporate Summary
7.19.2 Qilu Pharmaceutical Business Overview
7.19.3 Qilu Pharmaceutical Antihypertensive Major Product Offerings
7.19.4 Qilu Pharmaceutical Antihypertensive Sales and Revenue in Global (2017-2022)
7.19.5 Qilu Pharmaceutical Key News
7.20 HUALON
7.20.1 HUALON Corporate Summary
7.20.2 HUALON Business Overview
7.20.3 HUALON Antihypertensive Major Product Offerings
7.20.4 HUALON Antihypertensive Sales and Revenue in Global (2017-2022)
7.20.5 HUALON Key News
7.21 Dawnrays
7.21.1 Dawnrays Corporate Summary
7.21.2 Dawnrays Business Overview
7.21.3 Dawnrays Antihypertensive Major Product Offerings
7.21.4 Dawnrays Antihypertensive Sales and Revenue in Global (2017-2022)
7.21.5 Dawnrays Key News
7.22 HISUN Pharmceutical
7.22.1 HISUN Pharmceutical Corporate Summary
7.22.2 HISUN Pharmceutical Business Overview
7.22.3 HISUN Pharmceutical Antihypertensive Major Product Offerings
7.22.4 HISUN Pharmceutical Antihypertensive Sales and Revenue in Global (2017-2022)
7.22.5 HISUN Pharmceutical Key News
8 GLOBAL ANTIHYPERTENSIVE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Antihypertensive Production Capacity, 2017-2028
8.2 Antihypertensive Production Capacity of Key Manufacturers in Global Market
8.3 Global Antihypertensive Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ANTIHYPERTENSIVE SUPPLY CHAIN ANALYSIS
10.1 Antihypertensive Industry Value Chain
10.2 Antihypertensive Upstream Market
10.3 Antihypertensive Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antihypertensive Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Antihypertensive in Global Market
Table 2. Top Antihypertensive Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Antihypertensive Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Antihypertensive Revenue Share by Companies, 2017-2022
Table 5. Global Antihypertensive Sales by Companies, (K Units), 2017-2022
Table 6. Global Antihypertensive Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Antihypertensive Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Antihypertensive Product Type
Table 9. List of Global Tier 1 Antihypertensive Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antihypertensive Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antihypertensive Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Antihypertensive Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Antihypertensive Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Antihypertensive Sales (K Units), 2017-2022
Table 15. By Type - Global Antihypertensive Sales (K Units), 2023-2028
Table 16. By Application – Global Antihypertensive Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Antihypertensive Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Antihypertensive Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Antihypertensive Sales (K Units), 2017-2022
Table 20. By Application - Global Antihypertensive Sales (K Units), 2023-2028
Table 21. By Region – Global Antihypertensive Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Antihypertensive Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Antihypertensive Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Antihypertensive Sales (K Units), 2017-2022
Table 25. By Region - Global Antihypertensive Sales (K Units), 2023-2028
Table 26. By Country - North America Antihypertensive Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Antihypertensive Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Antihypertensive Sales, (K Units), 2017-2022
Table 29. By Country - North America Antihypertensive Sales, (K Units), 2023-2028
Table 30. By Country - Europe Antihypertensive Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Antihypertensive Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Antihypertensive Sales, (K Units), 2017-2022
Table 33. By Country - Europe Antihypertensive Sales, (K Units), 2023-2028
Table 34. By Region - Asia Antihypertensive Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Antihypertensive Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Antihypertensive Sales, (K Units), 2017-2022
Table 37. By Region - Asia Antihypertensive Sales, (K Units), 2023-2028
Table 38. By Country - South America Antihypertensive Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Antihypertensive Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Antihypertensive Sales, (K Units), 2017-2022
Table 41. By Country - South America Antihypertensive Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Antihypertensive Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Antihypertensive Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Antihypertensive Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Antihypertensive Sales, (K Units), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Antihypertensive Product Offerings
Table 48. Pfizer Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Norvatis Corporate Summary
Table 50. Norvatis Antihypertensive Product Offerings
Table 51. Norvatis Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Merck & Co. Corporate Summary
Table 53. Merck & Co. Antihypertensive Product Offerings
Table 54. Merck & Co. Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Sanofi Corporate Summary
Table 56. Sanofi Antihypertensive Product Offerings
Table 57. Sanofi Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. AstraZeneca Corporate Summary
Table 59. AstraZeneca Antihypertensive Product Offerings
Table 60. AstraZeneca Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. GSK Corporate Summary
Table 62. GSK Antihypertensive Product Offerings
Table 63. GSK Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Daiichi-Sankyo Corporate Summary
Table 65. Daiichi-Sankyo Antihypertensive Product Offerings
Table 66. Daiichi-Sankyo Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Boehringer-Ingelheim Corporate Summary
Table 68. Boehringer-Ingelheim Antihypertensive Product Offerings
Table 69. Boehringer-Ingelheim Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Bayer Corporate Summary
Table 71. Bayer Antihypertensive Product Offerings
Table 72. Bayer Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Johnson & Johnson Corporate Summary
Table 74. Johnson & Johnson Antihypertensive Product Offerings
Table 75. Johnson & Johnson Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Bristol-Myers Squibb Corporate Summary
Table 77. Bristol-Myers Squibb Antihypertensive Product Offerings
Table 78. Bristol-Myers Squibb Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Tekeda Corporate Summary
Table 80. Tekeda Antihypertensive Product Offerings
Table 81. Tekeda Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Ranbaxy Laboratories Corporate Summary
Table 83. Ranbaxy Laboratories Antihypertensive Product Offerings
Table 84. Ranbaxy Laboratories Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Shihuida Pharm Corporate Summary
Table 86. Shihuida Pharm Antihypertensive Product Offerings
Table 87. Shihuida Pharm Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Second Pharmaceutical Corporate Summary
Table 89. Second Pharmaceutical Antihypertensive Product Offerings
Table 90. Second Pharmaceutical Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 91. Lupin Limited. Corporate Summary
Table 92. Lupin Limited. Antihypertensive Product Offerings
Table 93. Lupin Limited. Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 94. Yangtze River Pharmaceutical Corporate Summary
Table 95. Yangtze River Pharmaceutical Antihypertensive Product Offerings
Table 96. Yangtze River Pharmaceutical Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 97. Hengrui Medicine Corporate Summary
Table 98. Hengrui Medicine Antihypertensive Product Offerings
Table 99. Hengrui Medicine Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 100. Qilu Pharmaceutical Corporate Summary
Table 101. Qilu Pharmaceutical Antihypertensive Product Offerings
Table 102. Qilu Pharmaceutical Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 103. HUALON Corporate Summary
Table 104. HUALON Antihypertensive Product Offerings
Table 105. HUALON Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 106. Dawnrays Corporate Summary
Table 107. Dawnrays Antihypertensive Product Offerings
Table 108. Dawnrays Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 109. HISUN Pharmceutical Corporate Summary
Table 110. HISUN Pharmceutical Antihypertensive Product Offerings
Table 111. HISUN Pharmceutical Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 112. Antihypertensive Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 113. Global Antihypertensive Capacity Market Share of Key Manufacturers, 2020-2022
Table 114. Global Antihypertensive Production by Region, 2017-2022 (K Units)
Table 115. Global Antihypertensive Production by Region, 2023-2028 (K Units)
Table 116. Antihypertensive Market Opportunities & Trends in Global Market
Table 117. Antihypertensive Market Drivers in Global Market
Table 118. Antihypertensive Market Restraints in Global Market
Table 119. Antihypertensive Raw Materials
Table 120. Antihypertensive Raw Materials Suppliers in Global Market
Table 121. Typical Antihypertensive Downstream
Table 122. Antihypertensive Downstream Clients in Global Market
Table 123. Antihypertensive Distributors and Sales Agents in Global Market
Table 1. Key Players of Antihypertensive in Global Market
Table 2. Top Antihypertensive Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Antihypertensive Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Antihypertensive Revenue Share by Companies, 2017-2022
Table 5. Global Antihypertensive Sales by Companies, (K Units), 2017-2022
Table 6. Global Antihypertensive Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Antihypertensive Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Antihypertensive Product Type
Table 9. List of Global Tier 1 Antihypertensive Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antihypertensive Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antihypertensive Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Antihypertensive Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Antihypertensive Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Antihypertensive Sales (K Units), 2017-2022
Table 15. By Type - Global Antihypertensive Sales (K Units), 2023-2028
Table 16. By Application – Global Antihypertensive Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Antihypertensive Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Antihypertensive Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Antihypertensive Sales (K Units), 2017-2022
Table 20. By Application - Global Antihypertensive Sales (K Units), 2023-2028
Table 21. By Region – Global Antihypertensive Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Antihypertensive Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Antihypertensive Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Antihypertensive Sales (K Units), 2017-2022
Table 25. By Region - Global Antihypertensive Sales (K Units), 2023-2028
Table 26. By Country - North America Antihypertensive Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Antihypertensive Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Antihypertensive Sales, (K Units), 2017-2022
Table 29. By Country - North America Antihypertensive Sales, (K Units), 2023-2028
Table 30. By Country - Europe Antihypertensive Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Antihypertensive Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Antihypertensive Sales, (K Units), 2017-2022
Table 33. By Country - Europe Antihypertensive Sales, (K Units), 2023-2028
Table 34. By Region - Asia Antihypertensive Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Antihypertensive Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Antihypertensive Sales, (K Units), 2017-2022
Table 37. By Region - Asia Antihypertensive Sales, (K Units), 2023-2028
Table 38. By Country - South America Antihypertensive Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Antihypertensive Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Antihypertensive Sales, (K Units), 2017-2022
Table 41. By Country - South America Antihypertensive Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Antihypertensive Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Antihypertensive Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Antihypertensive Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Antihypertensive Sales, (K Units), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Antihypertensive Product Offerings
Table 48. Pfizer Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Norvatis Corporate Summary
Table 50. Norvatis Antihypertensive Product Offerings
Table 51. Norvatis Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Merck & Co. Corporate Summary
Table 53. Merck & Co. Antihypertensive Product Offerings
Table 54. Merck & Co. Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Sanofi Corporate Summary
Table 56. Sanofi Antihypertensive Product Offerings
Table 57. Sanofi Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. AstraZeneca Corporate Summary
Table 59. AstraZeneca Antihypertensive Product Offerings
Table 60. AstraZeneca Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. GSK Corporate Summary
Table 62. GSK Antihypertensive Product Offerings
Table 63. GSK Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Daiichi-Sankyo Corporate Summary
Table 65. Daiichi-Sankyo Antihypertensive Product Offerings
Table 66. Daiichi-Sankyo Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Boehringer-Ingelheim Corporate Summary
Table 68. Boehringer-Ingelheim Antihypertensive Product Offerings
Table 69. Boehringer-Ingelheim Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Bayer Corporate Summary
Table 71. Bayer Antihypertensive Product Offerings
Table 72. Bayer Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Johnson & Johnson Corporate Summary
Table 74. Johnson & Johnson Antihypertensive Product Offerings
Table 75. Johnson & Johnson Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Bristol-Myers Squibb Corporate Summary
Table 77. Bristol-Myers Squibb Antihypertensive Product Offerings
Table 78. Bristol-Myers Squibb Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Tekeda Corporate Summary
Table 80. Tekeda Antihypertensive Product Offerings
Table 81. Tekeda Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Ranbaxy Laboratories Corporate Summary
Table 83. Ranbaxy Laboratories Antihypertensive Product Offerings
Table 84. Ranbaxy Laboratories Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Shihuida Pharm Corporate Summary
Table 86. Shihuida Pharm Antihypertensive Product Offerings
Table 87. Shihuida Pharm Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Second Pharmaceutical Corporate Summary
Table 89. Second Pharmaceutical Antihypertensive Product Offerings
Table 90. Second Pharmaceutical Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 91. Lupin Limited. Corporate Summary
Table 92. Lupin Limited. Antihypertensive Product Offerings
Table 93. Lupin Limited. Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 94. Yangtze River Pharmaceutical Corporate Summary
Table 95. Yangtze River Pharmaceutical Antihypertensive Product Offerings
Table 96. Yangtze River Pharmaceutical Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 97. Hengrui Medicine Corporate Summary
Table 98. Hengrui Medicine Antihypertensive Product Offerings
Table 99. Hengrui Medicine Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 100. Qilu Pharmaceutical Corporate Summary
Table 101. Qilu Pharmaceutical Antihypertensive Product Offerings
Table 102. Qilu Pharmaceutical Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 103. HUALON Corporate Summary
Table 104. HUALON Antihypertensive Product Offerings
Table 105. HUALON Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 106. Dawnrays Corporate Summary
Table 107. Dawnrays Antihypertensive Product Offerings
Table 108. Dawnrays Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 109. HISUN Pharmceutical Corporate Summary
Table 110. HISUN Pharmceutical Antihypertensive Product Offerings
Table 111. HISUN Pharmceutical Antihypertensive Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 112. Antihypertensive Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 113. Global Antihypertensive Capacity Market Share of Key Manufacturers, 2020-2022
Table 114. Global Antihypertensive Production by Region, 2017-2022 (K Units)
Table 115. Global Antihypertensive Production by Region, 2023-2028 (K Units)
Table 116. Antihypertensive Market Opportunities & Trends in Global Market
Table 117. Antihypertensive Market Drivers in Global Market
Table 118. Antihypertensive Market Restraints in Global Market
Table 119. Antihypertensive Raw Materials
Table 120. Antihypertensive Raw Materials Suppliers in Global Market
Table 121. Typical Antihypertensive Downstream
Table 122. Antihypertensive Downstream Clients in Global Market
Table 123. Antihypertensive Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Antihypertensive Segment by Type
Figure 2. Antihypertensive Segment by Application
Figure 3. Global Antihypertensive Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antihypertensive Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antihypertensive Revenue, 2017-2028 (US$, Mn)
Figure 7. Antihypertensive Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Antihypertensive Revenue in 2021
Figure 9. By Type - Global Antihypertensive Sales Market Share, 2017-2028
Figure 10. By Type - Global Antihypertensive Revenue Market Share, 2017-2028
Figure 11. By Type - Global Antihypertensive Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Antihypertensive Sales Market Share, 2017-2028
Figure 13. By Application - Global Antihypertensive Revenue Market Share, 2017-2028
Figure 14. By Application - Global Antihypertensive Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Antihypertensive Sales Market Share, 2017-2028
Figure 16. By Region - Global Antihypertensive Revenue Market Share, 2017-2028
Figure 17. By Country - North America Antihypertensive Revenue Market Share, 2017-2028
Figure 18. By Country - North America Antihypertensive Sales Market Share, 2017-2028
Figure 19. US Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Antihypertensive Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Antihypertensive Sales Market Share, 2017-2028
Figure 24. Germany Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 25. France Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Antihypertensive Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Antihypertensive Sales Market Share, 2017-2028
Figure 33. China Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 37. India Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Antihypertensive Revenue Market Share, 2017-2028
Figure 39. By Country - South America Antihypertensive Sales Market Share, 2017-2028
Figure 40. Brazil Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Antihypertensive Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Antihypertensive Sales Market Share, 2017-2028
Figure 44. Turkey Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 48. Global Antihypertensive Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Antihypertensive by Region, 2021 VS 2028
Figure 50. Antihypertensive Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Antihypertensive Segment by Type
Figure 2. Antihypertensive Segment by Application
Figure 3. Global Antihypertensive Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antihypertensive Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antihypertensive Revenue, 2017-2028 (US$, Mn)
Figure 7. Antihypertensive Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Antihypertensive Revenue in 2021
Figure 9. By Type - Global Antihypertensive Sales Market Share, 2017-2028
Figure 10. By Type - Global Antihypertensive Revenue Market Share, 2017-2028
Figure 11. By Type - Global Antihypertensive Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Antihypertensive Sales Market Share, 2017-2028
Figure 13. By Application - Global Antihypertensive Revenue Market Share, 2017-2028
Figure 14. By Application - Global Antihypertensive Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Antihypertensive Sales Market Share, 2017-2028
Figure 16. By Region - Global Antihypertensive Revenue Market Share, 2017-2028
Figure 17. By Country - North America Antihypertensive Revenue Market Share, 2017-2028
Figure 18. By Country - North America Antihypertensive Sales Market Share, 2017-2028
Figure 19. US Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Antihypertensive Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Antihypertensive Sales Market Share, 2017-2028
Figure 24. Germany Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 25. France Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Antihypertensive Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Antihypertensive Sales Market Share, 2017-2028
Figure 33. China Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 37. India Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Antihypertensive Revenue Market Share, 2017-2028
Figure 39. By Country - South America Antihypertensive Sales Market Share, 2017-2028
Figure 40. Brazil Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Antihypertensive Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Antihypertensive Sales Market Share, 2017-2028
Figure 44. Turkey Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Antihypertensive Revenue, (US$, Mn), 2017-2028
Figure 48. Global Antihypertensive Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Antihypertensive by Region, 2021 VS 2028
Figure 50. Antihypertensive Industry Value Chain
Figure 51. Marketing Channels
